Analysis of Gut Microbiota in Patients with Parkinson’s Disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Gut microbiota of patients with Parkinson’s disease and healthy volunteers was analyzed by the method of high throughput 16S rRNA sequencing of bacterial genomes. In patients with Parkinson’s diseases, changes in the content of 9 genera and 15 species of microorganisms were revealed: reduced content of Dorea, Bacteroides, Prevotella, Faecalibacterium, Bacteroides massiliensis, Stoquefichus massiliensis, Bacteroides coprocola, Blautia glucerasea, Dorea longicatena, Bacteroides dorei, Bacteroides plebeus, Prevotella copri, Coprococcus eutactus, and Ruminococcus callidus, and increased content of Christensenella, Catabacter, Lactobacillus, Oscillospira, Bifidobacterium, Christensenella minuta, Catabacter hongkongensis, Lactobacillus mucosae, Ruminococcus bromii, and Papillibacter cinnamivorans. This microbiological pattern of gut microflora can trigger local inflammation followed by aggregation of α-synuclein and generation of Lewy bodies.

About the authors

V. A. Petrov

Siberian State Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

I. V. Saltykova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

I. A. Zhukova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

V. M. Alifirova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

N. G. Zhukova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

Yu. B. Dorofeeva

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

A. V. Tyakht

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

B. A. Kovarsky

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

D. G. Alekseev

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

E. S. Kostryukova

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

Yu. S. Mironova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

O. P. Izhboldina

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

M. A. Nikitina

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

T. V. Perevozchikova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

E. A. Fait

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk

V. V. Babenko

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

M. T. Vakhitova

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow

V. M. Govorun

Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency; M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Moscow; Moscow

A. E. Sazonov

Siberian State Medical University, Ministry of Health of the Russian Federation; M. V. Lomonosov Moscow State University

Email: vyacheslav.a.petrov@mail.ru
Russian Federation, Tomsk; Moscow


Copyright (c) 2017 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies